
ESOT multi-organ registry
On March 5th 2021, ESOT opened a tender for a technical provider that will build the multi-organ registry. ESOT is seeking the support of...
New ESOT Member Area!
We are pleased to launch the new ESOT Member Area, an ever-evolving platform from which we are constantly striving to improve the accessibility and...
Technical & Logistical aspects of Performing Normothermic Regional Perfusion in Controlled Donation after Circulatory Death in Europe
A working group of European experts has summarised the current technique and logistical aspects as they are implemented in their countries and / or...
Cell Therapy and Organ Regeneration in Transplantation
REGISTER TODAY – CLICK HERE Registration to 2nd ECTORS Meeting is complimentary, but only registered participants will have access. The Programme is available here
ESOT Congress 2021: Abstract Submission Deadline EXTENDED
The abstract submission deadline for #ESOTcongress has been EXTENDED until Thursday 25th February at 23:59 CET.
The COVID-19 Vaccine Studies
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients...
Transplant International is looking for its publishing partner
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.
Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer – Open for comments until 06 April
This pre-print from TLJ 2.0 WS03 on ‘Managing Immunosuppressant Therapy in Potentially Cured Post-Kidney Transplant Cancer’ is now open for comments on Transplant Live....
Scientific Highlights – Transplantation Learning Journey TLJ 2.0
We are pleased to announce that our TLJ 2.0 report has been published and is available to read now. Providing a comprehensive summary of...